General Oncology

FEATURED CONTENT

Multidisciplinary Genetic Tumor Boards: Critical for Interpreting Tumor-Only Sequencing Results

One approach for improving recommendations based on tumor-only sequencing is use of a multidisciplinary genomic tumor board, in which researchers from a variety of backgrounds weigh in on the best way to interpret test results.
The Revival of a Forgotten Cancer Gene Therapy With Off-the-Shelf Potential

A universal cancer gene therapy from the early 2000s is headed into phase 2 trials, in light of renewed interest and outlier patients who are still alive at 10 years later.
In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home

Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?
What Do Surrogate End Points Actually Predict?

As understanding of cancer improves, drug development could become accelerated, necessitating a means for determining whether a drug is actually effective.
Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.

GENERAL ONCOLOGY CANCERS NEWS

A colon affected by ulcerative colitis.

How Safe Is Resumption of Checkpoint Inhibitor Therapy After an Initial Event of Immune-Mediated Diarrhea and Colitis?

June 20, 2019

Long-Term Follow-Up for Late Effects in Survivors of Childhood and Adolescent/Young Adult Cancers

Overall Cancer Survival Rates Up Among Adolescents, Young Adults

June 19, 2019

SN-MMR was strongly associated with OS, melanoma-specific survival, and DFS among patients with a po

Early MRD Status After CAR-T Administration Predicted PFS, OS

June 14, 2019

The authors of a recent review developed 6 crucial care points for treating pregnant patients with b

Study Confirms Teratogenicity of Valproic Acid, Topiramate

June 14, 2019

The combinatorial approach is not, furthermore, limited to chemotherapy.

Declining Use of Chemotherapy in the Last 2 Weeks of Life for Older Patients With Solid Tumor Cancers

June 13, 2019

Next post in General Oncology

A colon affected by ulcerative colitis.

How Safe Is Resumption of Checkpoint Inhibitor Therapy After an Initial Event of Immune-Mediated Diarrhea and Colitis?